• 文档语言：英文
• 文档大小：56KB
• 文档类型：PPT
• 发布时间：2017/6/9 14:45:10
• 相关网站：internet
• 下载
• 版权说明：本站所有资源来源于网络，版权为原作者所有，本站刊载，仅限于促进医药行业发展、科技进步之目的。如本站行为侵犯了您的合法权益，请来信告知，我们将妥善处理。给您带来不便，敬请原谅。
• 幻灯介绍：

In-stent Restenosis
SIRIUS: 8 Month Angiographic Follow-up Restenosis Rates
In-segment Restenosis
Sirolimus
Stent
Bare
Stent
91% reduction
p<0.001
Sirolimus
Stent
Bare
Stent
75% reduction
p<0.001
Late Lumen Loss (mm)
Sirolimus
Stent
Proximal Margin
p<0.001
SIRIUS: 8 Month Angiographic Follow-up Late Lumen Loss
Bare
Stent
In-stent
p<0.001
Distal Margin
p<0.001
Sirolimus
Stent
Bare
Stent
Sirolimus
Stent
Bare
Stent
Number of In-segment Restenosis Events Prevented per 100 Patients
All patients
SIRIUS: Restenosis Events Prevented
Diabetes
LAD
Small
Vessels
Long
Lesions
MACE
SIRIUS: Clinical Events Through 9 Months
Target Vessel Failure*
Sirolimus
Stent
Bare
Stent
Sirolimus
Stent
Bare
Stent
*Primary clinical endpoint; defined as
cardiac death, MI, TVR
p<0.001
p<0.001